{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6(Suppl )"],"submitter":["Leabman M"],"journal":["HemaSphere"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9429641"],"repository":["biostudies-literature"],"pubmed_title":["P1276: DOSE RESPONSE PROFILE OF IGM-2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON-HODGKIN’S LYMPHOMA"],"pmcid":["PMC9429641"],"pubmed_authors":["Qazi I","Leabman M","So J","Budde E","Gopal A","Li K","Takimoto C","Hart K","Kotturi M","Tang J","Hernandez G","Kim W","Keyt B","Sinclair A","Manley T","Ng C","Hinton P","Pandya D","Cheah C","Carroll S"],"additional_accession":[]},"is_claimable":false,"name":"P1276: DOSE RESPONSE PROFILE OF IGM-2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON-HODGKIN’S LYMPHOMA","description":null,"dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jun","modification":"2025-04-05T11:02:56.264Z","creation":"2025-02-19T02:49:22.311Z"},"accession":"S-EPMC9429641","cross_references":{}}